KCT0005772终止未知
The efficacy on dysuria and safety of combination therapy with terazosin and bethanechol in Benign Prostatic Hyperplasia patients with Underactive Bladder
ational Health Insurance Service Ilsan Hospital0 个研究点目标入组 123 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 123
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 0No Limit（—）
- 性别
- Male
入选标准
- •(1) Patients over 19 years diagnosed with benign prostatic hyperplasia
- •(2) Those with an IPSS total score of 8 or more and a maximum urine velocity of 15mL/s or less
- •(3) Those with BVE(Bladder Void Efficiency)<90
- •*BVE=(Voided Volume/(Voided Volume+Post Voided Residual)*100)
- •(4) Those who voluntarily decide to participate in this study and consent in writing to the subject's consent.
排除标准
- •(1) Patients with urinary tract stones, urethral stenosis or urinary tract infection
- •(2) Prostate cancer patients or patients who have undergone prostate surgery
- •(3) Patients who have undergone surgery due to bladder muscle obstruction or prostatic hyperplasia
- •(4) Patients diagnosed with cardiovascular disease, liver disease, orthostatic hypotension, hypertension or renal dysfunction
- •(5) Patients taking anticholinergic drugs, beta3-antagonists, and 5-alpha reductase inhibitors.
- •(6) Patients with malignant tumors in the urinary tract epithelium
- •(7) Those with hypersensitivity to alpha-blocker agents or cholinergic agents
- •(8) Those with a histoory of urinary tract related surgery
- •(9) Patients with mechanical obstruction of the gastrointestinal tract or urinary tract
- •(10) Convulsive gastrointestinal disease, gastric ulcer, acute gastrointestinal inflammatory disease
- •(11) peritonitis patients
- •(12) Vagus hypertonia patients
- •(13) Asthma patients
- •(14) Patients with hyperthyroidism
- •(15) Patients with coronary artery obstruction
- •(16) Patients with bradycardia, atrioventricular conduction disorder, and vasomotor instability
- •(17) Patients with epilepsy and Parkinsonism
- •(18) Patients who did not heal after undergoing gastric duct anastomosis
- •(19) Others who are inadequate to participate in this research when judged by the research director or the research manager
研究者
相似试验
已完成
4 期
Efficacy and safety of the combination dihydroartemisinin-piperaquine (DHA-PIP) for the treatment of uncomplicated Plasmodium falciparum malaria in Champasack province, Laos PDRInfection - Studies of infection and infectious agentsMalariaACTRN12618001650280Ministry of Health100
已完成
4 期
A clinical evaluation of safety of combination therapy with Rapid Onset Opioid and Short Acting Opioid.Cancer PainJPRN-UMIN000019224Kansai Electric Power Hospital30
已完成
不适用
Investigation on efficacy and safety of combination treatment with imidafenacin and mirabegron in patients with overactive bladder.overactive bladderJPRN-UMIN000016236Clinical Research Support Center Kyushu30
尚未招募
Unknown
Efficacy and Safety of a Compound Unani Sang-e-Jarahat,Mazu Sabz,Kath safed and Maeen in the Management of Kasrat-e-Tams(Menorrhagia)CTRI/2023/08/056429SHAMSA AHMAD
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20